If you can read this, either the style sheet didn't load or you have an older browser that doesn't support style sheets. Try clearing your browser cache and refreshing the page.

(Marketwatch)   Abbott kidney study halted over safety concerns. Costello relieved   (marketwatch.com) divider line 2
    More: Followup, Raymond James, business unit, Abbott Laboratories, chronic kidney disease, kidney diseases  
•       •       •

537 clicks; posted to Business » on 19 Oct 2012 at 9:25 AM (1 year ago)   |  Favorite    |   share:  Share on Twitter share via Email Share on Facebook   more»



2 Comments   (+0 »)
   
View Voting Results: Smartest and Funniest

Archived thread
 
2012-10-19 07:18:51 PM
Pharma news is always interesting.

Here's a great blog from a scientist in the business. He has some great analyses of industry trends beyond just the science:

Link
 
2012-10-19 10:29:06 PM

John Nash: Pharma news is always interesting.

Here's a great blog from a scientist in the business. He has some great analyses of industry trends beyond just the science:

Link


Word. Not only did he do a great article about FOOF, he also sometimes has better gossip about my own company than I do.
 
Displayed 2 of 2 comments

View Voting Results: Smartest and Funniest


This thread is archived, and closed to new comments.

Continue Farking
Submit a Link »






Report